SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001654954-18-010930
Filing Date
2018-10-09
Accepted
2018-10-09 17:27:36
Documents
4
Period of Report
2018-10-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT cbmg_8k.htm 8-K 30509
2 MATERIAL CONTRACTS cbmg_ex101.htm EX-10.1 308258
3 PRESS RELEASE cbmg_ex991.htm EX-99.1 12927
4 IMAGE cbmg_ex991000.jpg GRAPHIC 4532
  Complete submission text file 0001654954-18-010930.txt   359374
Mailing Address 19925 STEVENS CREEK BLVD., SUITE 100 CUPERTINO CA 95014
Business Address 19925 STEVENS CREEK BLVD., SUITE 100 CUPERTINO CA 95014 (408) 973-7884
Cellular Biomedicine Group, Inc. (Filer) CIK: 0001378624 (see all company filings)

IRS No.: 861032927 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36498 | Film No.: 181114429
SIC: 2836 Biological Products, (No Diagnostic Substances)